Franz Josef Gildehaus
Ludwig Maximilian University of Munich
78 Papers
352 Citations
Franz Josef Gildehaus is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Medicine & Radionuclide therapy. The author has an hindex of 19, co-authored 61 publications.
Chat about Author
Papers
[18F]SiTATE-PET/CT for detection of pheochromocytomas and paragangliomas: comparison of biochemical secretion, genotype and imaging metrics.
M. Onkes,P. Dahlmann,Alena Gesenhues,S. I. G. Gacula,Nabeel Mansour,Júnia R O L Schweizer,Isabel Stüfchen,C. Lottspeich,Katharina Wang,Matthias K Auer,Matthias Brendel,Alessa Fischer,Till Braunschweig,Franz Josef Gildehaus,Simon Lindner,C. Schmid-Tannwald,Thomas Pfluger,C. Auernhammer,S. Nölting,Rudolf A. Werner,M. Reincke,M. Bidlingmaier,M. Kroiss,Friederike Völter +23 more
TL;DR: This study evaluates [18F]SiTATE-PET/CT for diagnosing pheochromocytomas and paragangliomas, comparing imaging metrics to tumor marker levels and secretory activity in 34 patients, showing a 96.6% detection rate and correlations between imaging parameters and chromogranin A levels.
[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
L. Unterrainer,Lennert Eismann,Simon Lindner,Franz Josef Gildehaus,Johannes Toms,Jozefina Casuscelli,Adrien Holzgreve,Sophie C. Kunte,Clemens C. Cyran,Paula Menold,Alexander Karl,Marcus Unterrainer,Stephan Ledderose,C. Stief,P. Bartenstein,Alexander Kretschmer,G. B. Schulz +16 more
TL;DR: This innovative [68 Ga]Ga-FAPI-46 PET/CT method showed high specificity and negative predictive value in patients with bladder UC with a future potential to optimize therapy planning.
Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging
Letizia Vogler,Annamaria Ballweg,Bernd Bohr,Nils Briel,Karin Wind,M. Antons,L. Kunze,Johannes Gnörich,Simon Lindner,Franz Josef Gildehaus,Karlheinz Baumann,Peter Bartenstein,Guido Boening,Sibylle Ziegler,Johannes Levin,Andreas Zwergal,Günter U. Höglinger,Jochen Herms,Matthias Brendel +18 more
- 01 Jul 2023
TL;DR: Highlights • [18F]UCB-H was evaluated as a preclinical biomarker of synapse density in Alzheimer’s disease (AD) models and may be a more reliable surrogate of neurodegeneration than glucose metabolism in AD models.
[68Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study.
Lennert Eismann,Stephan Ledderose,Benazir Enzinger,Elena Berg,Thilo Westhofen,S. Rodler,G. Schulz,Johannes Toms,Adrien Holzgreve,Franz Josef Gildehaus,Matthias Brendel,Clemens Cyran,Marcus Unterrainer,C. Stief,P. Bartenstein,Boris Schlenker,L. Unterrainer +16 more
The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors.
Andreas Delker,Harun Ilhan,Christian Zach,J Brosch,Franz Josef Gildehaus,Sebastian Lehner,Peter Bartenstein,Guido Böning +7 more
TL;DR: It is found that the presence of two clearance phases can hamper accurate dose estimation based on a single-phase model, resulting in approximately 12.4 % dose underestimation, thus potentially resulting in overtreatment.